BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2420767)

  • 1. Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen.
    Triebel F; de Roquefeuil S; Blanc C; Charron DJ; Debre P
    Hum Immunol; 1986 Mar; 15(3):302-15. PubMed ID: 2420767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
    Linner KM; Monroy C; Bach FH; Gehrz RC
    Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD 1-8 antigens on human diphtheria toxoid T lymphocyte clones: expression and modulation by TPA, sodium butyrate, and 5-azacytidine.
    Triebel F; De Roquefeuil S; Bernard A; Blanc C; Debre P
    Hum Immunol; 1986 Jul; 16(3):221-33. PubMed ID: 2424873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.
    Odum N; Morling N; Platz P; Hofmann B; Ryder LP; Heilmann C; Pedersen FK; Nielsen LP; Friis J; Svejgaard A
    Ann Rheum Dis; 1987 Nov; 46(11):846-52. PubMed ID: 2827591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR antigens render interleukin-2-producer T lymphocytes sensitive to interleukin-1.
    Palacios R
    Scand J Immunol; 1981 Sep; 14(3):321-6. PubMed ID: 6173920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
    Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
    Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific T cell clones restricted by DR, DRw53 (MT), or DP (SB) Class II HLA molecules. Inhibition studies with monoclonal HLA-specific antibodies.
    Qvigstad E; Gaudernack G; Thorsby E
    Hum Immunol; 1984 Dec; 11(4):207-17. PubMed ID: 6210280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High and low density PHA- (but not ConA-) activated T cells stimulate the autologous mixed lymphocyte reaction.
    Brahmi Z; Thomas JE
    Ann Inst Pasteur Immunol (1985); 1985; 136D(3):245-58. PubMed ID: 3006583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
    Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
    Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The inhibitory effects of anti class II monoclonal antibodies against the proliferative response of autoreactive T-cell clone].
    Hasegawa H; Ikeda H; Katagiri M
    Hokkaido Igaku Zasshi; 1985 May; 60(3):368-74. PubMed ID: 3160641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ.
    Ottenhoff TH; Elferink DG; Hermans J; de Vries RR
    Hum Immunol; 1985 Jun; 13(2):105-16. PubMed ID: 2409060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.
    Lehner T; Jones T
    Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.